A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
A coronavirus vaccine in development by Australia\'s University of Queensland (UQ) was declared ready to progress to later-stage clinical trials ahead of schedule on Friday, following promising Phase 1 results.
Effectiveness of the Sputnik V vaccine against the coronavirus according to the results of the first interim analysis of Phase Three clinical trials in Russia is at 92%, the report of the Russian Direct Investment Fund (RDIF) said.
Health authorities in Vanuatu have announced the first confirmed case of the coronavirus in the island country located in the South Pacific Ocean, which was of a few countries that were coronavirus free until now.
South Africa on Monday launched the country\'s third coronavirus vaccine trial, which tests whether an experimental vaccine can protect people from contracting the novel coronavirus or developing serious symptoms.
Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against coronavirus in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.